Streetbeat News

Analyst Ratings

BNTC

JMP Securities analyst Silvan Tuerkcan has maintained a Market Outperform rating on Benitec Biopharma (NASDAQ:BNTC) and increased the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:14 pm

XP

XP Inc. shares are experiencing an uptick following an upgrade from Neutral to Outperform by Banco Bradesco BBI S.A, which also set a price target of $32 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:11 pm

BTCUSD

Despite Bitcoin's (BTC) recent dip below $40,000, technical analysts remain optimistic about an upcoming rebound. The cryptocurrency experienced a 10% drop from highs near $48,000, but analysts like Ali Charts and CryptoDonAlt view the pullback as temporary, citing the 'Sentiment Cycle' and a bullish chart pattern. While opinions vary, with some expecting further declines, others, including ARK Invest CEO Cathie Wood, are bullish on Bitcoin's long-term prospects, especially with the upcoming Bitcoin halving event.

Portfolio Pulse from Khyathi Dalal

January 24, 2024 | 5:10 pm

TXN

Mizuho analyst Vijay Rakesh has maintained a Neutral rating on Texas Instruments (NASDAQ:TXN) and reduced the price target from $170 to $164.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:08 pm

AMD

Shares of Advanced Micro Devices (AMD) are trading higher following an upgrade from Neutral to Buy by New Street Research, which also set a price target of $215 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:06 pm

PNW

Mizuho analyst Anthony Crowdell has maintained a Buy rating on Pinnacle West Capital (NYSE:PNW) but has reduced the price target from $79 to $77.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:06 pm

MMM

Mizuho analyst Brett Linzey has maintained a Neutral rating on 3M (NYSE:MMM) and reduced the price target from $120 to $105.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:03 pm

NDAQ

UBS has maintained a Neutral rating for Nasdaq (NASDAQ:NDAQ) and increased its price target from $56.00 to $60.00. Nasdaq's shares are currently trading up at $58.99, and the new price target suggests a modest upside of 1.71%. Nasdaq operates in various segments, including market services, information services, corporate services, and market technology.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm

MOS

Four analysts have recently updated their ratings on Mosaic (NYSE:MOS), showing a mix of indifference and slight bullishness. The average 12-month price target is now $36.25, down 6.26% from previous estimates, with a high of $42.00 and a low of $34.00. Analysts from Mizuho, Wells Fargo, Barclays, and RBC Capital have adjusted their price targets and ratings, reflecting a nuanced view of Mosaic's market position. Mosaic, a major phosphate and potash producer, has seen a -33.66% decline in revenue growth and faces profitability challenges with a net margin of -0.12% and ROE of -0.03%. Despite this, Mosaic maintains a healthy debt-to-equity ratio of 0.32.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm

SYF

Piper Sandler has reaffirmed its Overweight rating on Synchrony Financial (NYSE:SYF) and increased its price target from $46.00 to $48.00. Synchrony Financial's stock has risen 1.01% in the last 24 hours to $37.82. The new price target suggests a potential upside of 26.92% from the current price. Synchrony Financial is a major provider of private-label credit cards in the U.S.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm